Analyses / Public Summary / 119 · HRES 1117 Public Summary

119-HRES-1117 Journalist Public Summary

119 · HRES 1117 Expressing support for the designation of March as "Multiple System Atrophy Awareness Month" to strengthen public awareness of this neurodegenerative disorder.

A House resolution to recognize March as Multiple System Atrophy Awareness Month and signal support for research; it’s symbolic (no new law or funding) but aims to boost attention to a rare, often fatal disease and reduce misdiagnosis.

Published
17 Mar 2026
Updated
17 Mar 2026
Tags
public-summary · health · House simple resolution
Unvetted
01 · Section

Headline Summary

The House is considering a symbolic resolution to recognize March as Multiple System Atrophy Awareness Month and to voice support for research into this rare, often fatal neurological disease.

02 · Section

What It Does

This is a House simple resolution that would recognize March as “Multiple System Atrophy (MSA) Awareness Month.” It expresses support for research related to MSA but does not change law, create programs, or appropriate money. The text highlights that MSA can impair walking, eating, and speaking; is frequently misdiagnosed; has no known cure; and that raising awareness can aid earlier diagnosis and build momentum for research.

Estimated U.S. patients (lower bound)
25000people
Estimated U.S. patients (upper bound)
75000people
Congress
119th Congress
03 · Section

Who’s For It

  • Sponsor: Rep. Mullin submitted the resolution in the House, presenting it as an effort to boost awareness and support research on MSA.
  • Rare-disease advocates and families affected by MSA, who argue that public recognition can shorten time to diagnosis and build pressure for clinical trials and research dollars.
  • Academic and clinical researchers focused on neurodegenerative disease, who contend that visibility helps with patient referrals, data collection, and grant competitiveness.
04 · Section

Who’s Against It

  • No organized opposition noted in the provided record.
  • Skeptics of symbolic measures may question using floor time for nonbinding resolutions rather than bills that directly fund research or patient services.
  • Some may prefer prioritizing comprehensive rare-disease funding packages instead of adding another awareness month.
05 · Section

What’s Next

As of March 16, 2026, the resolution was referred to the House Committee on Energy and Commerce. Next steps could include committee consideration and a House floor vote. If adopted, it remains a House statement (not sent to the Senate or the President) and takes effect as an expression of support rather than a new law.

Discussion